MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
详细信息 查看全文
- 作者：Lanlan Li ; Jiayi Wang ; Yue Zhang ; Yan Zhang ; Lifang Ma ; Wenhao Weng ; Yongxia Qiao ; Weifan Xiao ; Hongmei Wang ; Wenjun Yu ; Qiuhui Pan ; Yunyan He ; Fenyong Sun
- 关键词：HCC ; hepatocellular carcinoma ; IF ; immunofluorescence ; IHC ; immunohistochemistry ; TMA ; tissue microarray analysis ; MTT ; 3-(4 ; 5-dimethylthiazol-2-yl)-2 ; 5-diphenyltetrazolium bromide
- 刊名：FEBS Letters
- 出版年：11 December, 2013
- 年：2013
- 卷：587
- 期：24
- 页码：3921-3927
- 全文大小：1805 K
文摘
Mitogen-activated protein kinase kinase 1 (MAP2K1/MEK1) as well as Yes-associated protein (YAP), the downstream effector of Hippo signaling pathway, is linked to hepatocarcinogenesis. However, little is known about whether and how MEK1 interacts with YAP. In this study, we find that MEK1-YAP interaction is critical for liver cancer cell proliferation and maintenance of transformed phenotypes both in vitro and in vivo. Moreover, MEK1 and YAP proteins are closely correlated in human liver cancer samples. Mechanistically, inhibition of MEK1 by both PD98059 and U0126 as well as RNAi reduces beta-transducin repeat containing E3 ubiquitin protein ligase (BTRC), which acts as a potential endogenous YAP protector.